nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCB11—Rosuvastatin—atherosclerosis	0.0882	0.124	CbGbCtD
Daunorubicin—ABCB11—Pravastatin—atherosclerosis	0.0802	0.112	CbGbCtD
Daunorubicin—ABCC1—Rosuvastatin—atherosclerosis	0.0626	0.0878	CbGbCtD
Daunorubicin—ABCC2—Ezetimibe—atherosclerosis	0.0464	0.065	CbGbCtD
Daunorubicin—ABCC2—Simvastatin—atherosclerosis	0.0431	0.0604	CbGbCtD
Daunorubicin—ABCC2—Pravastatin—atherosclerosis	0.0422	0.0591	CbGbCtD
Daunorubicin—ABCC2—Lovastatin—atherosclerosis	0.0422	0.0591	CbGbCtD
Daunorubicin—ABCG2—Rosuvastatin—atherosclerosis	0.0419	0.0587	CbGbCtD
Daunorubicin—ABCG2—Ezetimibe—atherosclerosis	0.0419	0.0587	CbGbCtD
Daunorubicin—ABCG2—Pravastatin—atherosclerosis	0.0381	0.0534	CbGbCtD
Daunorubicin—CYP3A5—Rosuvastatin—atherosclerosis	0.0232	0.0325	CbGbCtD
Daunorubicin—CYP3A5—Simvastatin—atherosclerosis	0.0216	0.0303	CbGbCtD
Daunorubicin—CYP3A5—Lovastatin—atherosclerosis	0.0211	0.0296	CbGbCtD
Daunorubicin—CYP3A5—Pravastatin—atherosclerosis	0.0211	0.0296	CbGbCtD
Daunorubicin—ABCB1—Ezetimibe—atherosclerosis	0.0151	0.0212	CbGbCtD
Daunorubicin—ABCB1—Simvastatin—atherosclerosis	0.0141	0.0197	CbGbCtD
Daunorubicin—ABCB1—Pravastatin—atherosclerosis	0.0138	0.0193	CbGbCtD
Daunorubicin—ABCB1—Lovastatin—atherosclerosis	0.0138	0.0193	CbGbCtD
Daunorubicin—CYP3A4—Rosuvastatin—atherosclerosis	0.00906	0.0127	CbGbCtD
Daunorubicin—CYP3A4—Ezetimibe—atherosclerosis	0.00906	0.0127	CbGbCtD
Daunorubicin—CYP3A4—Simvastatin—atherosclerosis	0.00842	0.0118	CbGbCtD
Daunorubicin—CYP3A4—Pravastatin—atherosclerosis	0.00824	0.0115	CbGbCtD
Daunorubicin—CYP3A4—Lovastatin—atherosclerosis	0.00824	0.0115	CbGbCtD
Daunorubicin—TOP2B—Pitavastatin—Rosuvastatin—atherosclerosis	0.00275	0.634	CbGdCrCtD
Daunorubicin—Doxorubicin—NOS3—atherosclerosis	0.0013	0.509	CrCbGaD
Daunorubicin—Doxorubicin—NOS2—atherosclerosis	0.00125	0.491	CrCbGaD
Daunorubicin—ABCC6—connective tissue—atherosclerosis	0.000858	0.0601	CbGeAlD
Daunorubicin—YWHAG—connective tissue—atherosclerosis	0.000808	0.0566	CbGeAlD
Daunorubicin—TOP2B—connective tissue—atherosclerosis	0.000779	0.0546	CbGeAlD
Daunorubicin—ABCC6—cardiovascular system—atherosclerosis	0.000747	0.0523	CbGeAlD
Daunorubicin—YWHAG—cardiovascular system—atherosclerosis	0.000703	0.0493	CbGeAlD
Daunorubicin—TOP2B—cardiovascular system—atherosclerosis	0.000678	0.0475	CbGeAlD
Daunorubicin—ABCC6—adipose tissue—atherosclerosis	0.000659	0.0461	CbGeAlD
Daunorubicin—YWHAG—adipose tissue—atherosclerosis	0.00062	0.0435	CbGeAlD
Daunorubicin—TOP2B—adipose tissue—atherosclerosis	0.000598	0.0419	CbGeAlD
Daunorubicin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000553	0.00417	CcSEcCtD
Daunorubicin—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.000545	0.126	CbGdCrCtD
Daunorubicin—Dysuria—Pravastatin—atherosclerosis	0.000535	0.00403	CcSEcCtD
Daunorubicin—Sinusitis—Simvastatin—atherosclerosis	0.000529	0.00399	CcSEcCtD
Daunorubicin—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.000521	0.12	CbGdCrCtD
Daunorubicin—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.000521	0.12	CbGdCrCtD
Daunorubicin—Depression—Pravastatin—atherosclerosis	0.000508	0.00383	CcSEcCtD
Daunorubicin—Stomatitis—Niacin—atherosclerosis	0.000505	0.00381	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000503	0.00379	CcSEcCtD
Daunorubicin—Flushing—Lovastatin—atherosclerosis	0.000502	0.00379	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.0005	0.00377	CcSEcCtD
Daunorubicin—Myocardial infarction—Pravastatin—atherosclerosis	0.0005	0.00377	CcSEcCtD
Daunorubicin—Flushing—Ezetimibe—atherosclerosis	0.000493	0.00372	CcSEcCtD
Daunorubicin—Chills—Lovastatin—atherosclerosis	0.000486	0.00366	CcSEcCtD
Daunorubicin—Cough—Rosuvastatin—atherosclerosis	0.000485	0.00366	CcSEcCtD
Daunorubicin—Sinusitis—Pravastatin—atherosclerosis	0.000478	0.00361	CcSEcCtD
Daunorubicin—Alopecia—Lovastatin—atherosclerosis	0.000478	0.00361	CcSEcCtD
Daunorubicin—Myalgia—Rosuvastatin—atherosclerosis	0.000473	0.00357	CcSEcCtD
Daunorubicin—Arthralgia—Rosuvastatin—atherosclerosis	0.000473	0.00357	CcSEcCtD
Daunorubicin—POR—adipose tissue—atherosclerosis	0.000471	0.033	CbGeAlD
Daunorubicin—Flushing—Simvastatin—atherosclerosis	0.00047	0.00354	CcSEcCtD
Daunorubicin—Alopecia—Ezetimibe—atherosclerosis	0.000469	0.00354	CcSEcCtD
Daunorubicin—Rhinitis—Niacin—atherosclerosis	0.000466	0.00351	CcSEcCtD
Daunorubicin—Erythema—Ezetimibe—atherosclerosis	0.000462	0.00349	CcSEcCtD
Daunorubicin—ABCC6—liver—atherosclerosis	0.000462	0.0324	CbGeAlD
Daunorubicin—Dysgeusia—Lovastatin—atherosclerosis	0.000461	0.00348	CcSEcCtD
Daunorubicin—Rhinitis—Pravastatin—atherosclerosis	0.000459	0.00346	CcSEcCtD
Daunorubicin—Confusional state—Rosuvastatin—atherosclerosis	0.000457	0.00345	CcSEcCtD
Daunorubicin—Back pain—Lovastatin—atherosclerosis	0.000456	0.00344	CcSEcCtD
Daunorubicin—Chills—Simvastatin—atherosclerosis	0.000454	0.00343	CcSEcCtD
Daunorubicin—Infection—Rosuvastatin—atherosclerosis	0.000451	0.0034	CcSEcCtD
Daunorubicin—Visual impairment—Niacin—atherosclerosis	0.000448	0.00338	CcSEcCtD
Daunorubicin—Alopecia—Simvastatin—atherosclerosis	0.000447	0.00337	CcSEcCtD
Daunorubicin—Back pain—Ezetimibe—atherosclerosis	0.000447	0.00337	CcSEcCtD
Daunorubicin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000444	0.00335	CcSEcCtD
Daunorubicin—Tremor—Lovastatin—atherosclerosis	0.000441	0.00333	CcSEcCtD
Daunorubicin—Visual impairment—Pravastatin—atherosclerosis	0.000441	0.00333	CcSEcCtD
Daunorubicin—Erythema—Simvastatin—atherosclerosis	0.000441	0.00332	CcSEcCtD
Daunorubicin—TOP2A—adipose tissue—atherosclerosis	0.000439	0.0308	CbGeAlD
Daunorubicin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000437	0.0033	CcSEcCtD
Daunorubicin—YWHAG—liver—atherosclerosis	0.000435	0.0305	CbGeAlD
Daunorubicin—Tinnitus—Niacin—atherosclerosis	0.000433	0.00327	CcSEcCtD
Daunorubicin—Dysgeusia—Simvastatin—atherosclerosis	0.000431	0.00326	CcSEcCtD
Daunorubicin—Flushing—Niacin—atherosclerosis	0.000431	0.00325	CcSEcCtD
Daunorubicin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000429	0.00323	CcSEcCtD
Daunorubicin—Anaemia—Ezetimibe—atherosclerosis	0.000427	0.00322	CcSEcCtD
Daunorubicin—Tinnitus—Pravastatin—atherosclerosis	0.000427	0.00322	CcSEcCtD
Daunorubicin—Malaise—Lovastatin—atherosclerosis	0.000425	0.0032	CcSEcCtD
Daunorubicin—Cardiac disorder—Pravastatin—atherosclerosis	0.000425	0.0032	CcSEcCtD
Daunorubicin—Flushing—Pravastatin—atherosclerosis	0.000425	0.0032	CcSEcCtD
Daunorubicin—XDH—liver—atherosclerosis	0.000424	0.0297	CbGeAlD
Daunorubicin—Leukopenia—Lovastatin—atherosclerosis	0.000422	0.00318	CcSEcCtD
Daunorubicin—TOP2B—liver—atherosclerosis	0.000419	0.0294	CbGeAlD
Daunorubicin—Chills—Niacin—atherosclerosis	0.000417	0.00315	CcSEcCtD
Daunorubicin—Malaise—Ezetimibe—atherosclerosis	0.000417	0.00314	CcSEcCtD
Daunorubicin—Arrhythmia—Niacin—atherosclerosis	0.000415	0.00313	CcSEcCtD
Daunorubicin—ABCB11—liver—atherosclerosis	0.000414	0.029	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000413	0.00312	CcSEcCtD
Daunorubicin—Tremor—Simvastatin—atherosclerosis	0.000413	0.00311	CcSEcCtD
Daunorubicin—Alopecia—Niacin—atherosclerosis	0.000411	0.0031	CcSEcCtD
Daunorubicin—Chills—Pravastatin—atherosclerosis	0.000411	0.0031	CcSEcCtD
Daunorubicin—Insomnia—Rosuvastatin—atherosclerosis	0.00041	0.0031	CcSEcCtD
Daunorubicin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000409	0.00308	CcSEcCtD
Daunorubicin—Arrhythmia—Pravastatin—atherosclerosis	0.000409	0.00308	CcSEcCtD
Daunorubicin—Palpitations—Ezetimibe—atherosclerosis	0.000408	0.00308	CcSEcCtD
Daunorubicin—Anaemia—Simvastatin—atherosclerosis	0.000407	0.00307	CcSEcCtD
Daunorubicin—Erythema—Niacin—atherosclerosis	0.000405	0.00305	CcSEcCtD
Daunorubicin—Alopecia—Pravastatin—atherosclerosis	0.000404	0.00305	CcSEcCtD
Daunorubicin—Cough—Ezetimibe—atherosclerosis	0.000403	0.00304	CcSEcCtD
Daunorubicin—Myalgia—Lovastatin—atherosclerosis	0.000401	0.00303	CcSEcCtD
Daunorubicin—Arthralgia—Lovastatin—atherosclerosis	0.000401	0.00303	CcSEcCtD
Daunorubicin—Chest pain—Lovastatin—atherosclerosis	0.000401	0.00303	CcSEcCtD
Daunorubicin—Anxiety—Lovastatin—atherosclerosis	0.0004	0.00301	CcSEcCtD
Daunorubicin—Hypertension—Ezetimibe—atherosclerosis	0.000399	0.00301	CcSEcCtD
Daunorubicin—Malaise—Simvastatin—atherosclerosis	0.000397	0.003	CcSEcCtD
Daunorubicin—Discomfort—Lovastatin—atherosclerosis	0.000396	0.00299	CcSEcCtD
Daunorubicin—Leukopenia—Simvastatin—atherosclerosis	0.000394	0.00298	CcSEcCtD
Daunorubicin—Arthralgia—Ezetimibe—atherosclerosis	0.000393	0.00297	CcSEcCtD
Daunorubicin—Chest pain—Ezetimibe—atherosclerosis	0.000393	0.00297	CcSEcCtD
Daunorubicin—Myalgia—Ezetimibe—atherosclerosis	0.000393	0.00297	CcSEcCtD
Daunorubicin—Dry mouth—Lovastatin—atherosclerosis	0.000392	0.00296	CcSEcCtD
Daunorubicin—Dysgeusia—Pravastatin—atherosclerosis	0.00039	0.00294	CcSEcCtD
Daunorubicin—Discomfort—Ezetimibe—atherosclerosis	0.000389	0.00293	CcSEcCtD
Daunorubicin—Pain—Rosuvastatin—atherosclerosis	0.000388	0.00293	CcSEcCtD
Daunorubicin—Constipation—Rosuvastatin—atherosclerosis	0.000388	0.00293	CcSEcCtD
Daunorubicin—Confusional state—Lovastatin—atherosclerosis	0.000388	0.00292	CcSEcCtD
Daunorubicin—Dry mouth—Ezetimibe—atherosclerosis	0.000385	0.0029	CcSEcCtD
Daunorubicin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000384	0.0029	CcSEcCtD
Daunorubicin—CYP1B1—connective tissue—atherosclerosis	0.000383	0.0269	CbGeAlD
Daunorubicin—Infection—Lovastatin—atherosclerosis	0.000382	0.00288	CcSEcCtD
Daunorubicin—Confusional state—Ezetimibe—atherosclerosis	0.00038	0.00287	CcSEcCtD
Daunorubicin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000377	0.00284	CcSEcCtD
Daunorubicin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000376	0.00284	CcSEcCtD
Daunorubicin—Arthralgia—Simvastatin—atherosclerosis	0.000375	0.00283	CcSEcCtD
Daunorubicin—Myalgia—Simvastatin—atherosclerosis	0.000375	0.00283	CcSEcCtD
Daunorubicin—Chest pain—Simvastatin—atherosclerosis	0.000375	0.00283	CcSEcCtD
Daunorubicin—Infection—Ezetimibe—atherosclerosis	0.000375	0.00283	CcSEcCtD
Daunorubicin—ABCC10—adipose tissue—atherosclerosis	0.000374	0.0262	CbGeAlD
Daunorubicin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000374	0.00282	CcSEcCtD
Daunorubicin—Anxiety—Simvastatin—atherosclerosis	0.000374	0.00282	CcSEcCtD
Daunorubicin—Tremor—Pravastatin—atherosclerosis	0.000373	0.00282	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000371	0.0028	CcSEcCtD
Daunorubicin—Discomfort—Simvastatin—atherosclerosis	0.000371	0.0028	CcSEcCtD
Daunorubicin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00037	0.00279	CcSEcCtD
Daunorubicin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000369	0.00279	CcSEcCtD
Daunorubicin—Anaemia—Pravastatin—atherosclerosis	0.000368	0.00278	CcSEcCtD
Daunorubicin—Anorexia—Lovastatin—atherosclerosis	0.000366	0.00276	CcSEcCtD
Daunorubicin—Syncope—Niacin—atherosclerosis	0.000363	0.00274	CcSEcCtD
Daunorubicin—Confusional state—Simvastatin—atherosclerosis	0.000363	0.00274	CcSEcCtD
Daunorubicin—Leukopenia—Niacin—atherosclerosis	0.000362	0.00273	CcSEcCtD
Daunorubicin—Urticaria—Rosuvastatin—atherosclerosis	0.00036	0.00272	CcSEcCtD
Daunorubicin—Oedema—Simvastatin—atherosclerosis	0.00036	0.00271	CcSEcCtD
Daunorubicin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00036	0.00271	CcSEcCtD
Daunorubicin—Malaise—Pravastatin—atherosclerosis	0.000359	0.00271	CcSEcCtD
Daunorubicin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000359	0.00271	CcSEcCtD
Daunorubicin—Palpitations—Niacin—atherosclerosis	0.000358	0.0027	CcSEcCtD
Daunorubicin—Infection—Simvastatin—atherosclerosis	0.000357	0.0027	CcSEcCtD
Daunorubicin—Leukopenia—Pravastatin—atherosclerosis	0.000357	0.00269	CcSEcCtD
Daunorubicin—Loss of consciousness—Niacin—atherosclerosis	0.000356	0.00268	CcSEcCtD
Daunorubicin—Cough—Niacin—atherosclerosis	0.000353	0.00266	CcSEcCtD
Daunorubicin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000352	0.00266	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00035	0.00264	CcSEcCtD
Daunorubicin—Insomnia—Lovastatin—atherosclerosis	0.000348	0.00262	CcSEcCtD
Daunorubicin—Cough—Pravastatin—atherosclerosis	0.000348	0.00262	CcSEcCtD
Daunorubicin—Myalgia—Niacin—atherosclerosis	0.000344	0.0026	CcSEcCtD
Daunorubicin—Arthralgia—Niacin—atherosclerosis	0.000344	0.0026	CcSEcCtD
Daunorubicin—Hypertension—Pravastatin—atherosclerosis	0.000344	0.00259	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000344	0.00259	CcSEcCtD
Daunorubicin—Anorexia—Simvastatin—atherosclerosis	0.000343	0.00259	CcSEcCtD
Daunorubicin—Dyspnoea—Lovastatin—atherosclerosis	0.000343	0.00259	CcSEcCtD
Daunorubicin—Insomnia—Ezetimibe—atherosclerosis	0.000341	0.00257	CcSEcCtD
Daunorubicin—Arthralgia—Pravastatin—atherosclerosis	0.000339	0.00256	CcSEcCtD
Daunorubicin—Chest pain—Pravastatin—atherosclerosis	0.000339	0.00256	CcSEcCtD
Daunorubicin—Myalgia—Pravastatin—atherosclerosis	0.000339	0.00256	CcSEcCtD
Daunorubicin—Anxiety—Pravastatin—atherosclerosis	0.000338	0.00255	CcSEcCtD
Daunorubicin—Dry mouth—Niacin—atherosclerosis	0.000337	0.00254	CcSEcCtD
Daunorubicin—Dyspnoea—Ezetimibe—atherosclerosis	0.000336	0.00254	CcSEcCtD
Daunorubicin—Discomfort—Pravastatin—atherosclerosis	0.000335	0.00253	CcSEcCtD
Daunorubicin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000334	0.00252	CcSEcCtD
Daunorubicin—Decreased appetite—Lovastatin—atherosclerosis	0.000334	0.00252	CcSEcCtD
Daunorubicin—CYP1B1—cardiovascular system—atherosclerosis	0.000334	0.0234	CbGeAlD
Daunorubicin—Fatigue—Lovastatin—atherosclerosis	0.000331	0.0025	CcSEcCtD
Daunorubicin—POR—liver—atherosclerosis	0.000331	0.0232	CbGeAlD
Daunorubicin—Oedema—Niacin—atherosclerosis	0.00033	0.00249	CcSEcCtD
Daunorubicin—Anaphylactic shock—Niacin—atherosclerosis	0.00033	0.00249	CcSEcCtD
Daunorubicin—Pain—Lovastatin—atherosclerosis	0.000329	0.00248	CcSEcCtD
Daunorubicin—Constipation—Lovastatin—atherosclerosis	0.000329	0.00248	CcSEcCtD
Daunorubicin—Confusional state—Pravastatin—atherosclerosis	0.000328	0.00247	CcSEcCtD
Daunorubicin—Decreased appetite—Ezetimibe—atherosclerosis	0.000328	0.00247	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000328	0.00247	CcSEcCtD
Daunorubicin—Asthenia—Rosuvastatin—atherosclerosis	0.000325	0.00246	CcSEcCtD
Daunorubicin—Insomnia—Simvastatin—atherosclerosis	0.000325	0.00245	CcSEcCtD
Daunorubicin—Oedema—Pravastatin—atherosclerosis	0.000325	0.00245	CcSEcCtD
Daunorubicin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000325	0.00245	CcSEcCtD
Daunorubicin—Fatigue—Ezetimibe—atherosclerosis	0.000325	0.00245	CcSEcCtD
Daunorubicin—Shock—Niacin—atherosclerosis	0.000325	0.00245	CcSEcCtD
Daunorubicin—Infection—Pravastatin—atherosclerosis	0.000323	0.00244	CcSEcCtD
Daunorubicin—Pain—Ezetimibe—atherosclerosis	0.000322	0.00243	CcSEcCtD
Daunorubicin—Constipation—Ezetimibe—atherosclerosis	0.000322	0.00243	CcSEcCtD
Daunorubicin—Tachycardia—Niacin—atherosclerosis	0.000322	0.00243	CcSEcCtD
Daunorubicin—Pruritus—Rosuvastatin—atherosclerosis	0.000321	0.00242	CcSEcCtD
Daunorubicin—Dyspnoea—Simvastatin—atherosclerosis	0.000321	0.00242	CcSEcCtD
Daunorubicin—Hyperhidrosis—Niacin—atherosclerosis	0.000319	0.00241	CcSEcCtD
Daunorubicin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000318	0.0024	CcSEcCtD
Daunorubicin—Feeling abnormal—Lovastatin—atherosclerosis	0.000317	0.00239	CcSEcCtD
Daunorubicin—Anorexia—Niacin—atherosclerosis	0.000315	0.00237	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000314	0.00237	CcSEcCtD
Daunorubicin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000314	0.00237	CcSEcCtD
Daunorubicin—Decreased appetite—Simvastatin—atherosclerosis	0.000313	0.00236	CcSEcCtD
Daunorubicin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000311	0.00234	CcSEcCtD
Daunorubicin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00031	0.00234	CcSEcCtD
Daunorubicin—Fatigue—Simvastatin—atherosclerosis	0.00031	0.00234	CcSEcCtD
Daunorubicin—Anorexia—Pravastatin—atherosclerosis	0.00031	0.00234	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000308	0.00233	CcSEcCtD
Daunorubicin—Constipation—Simvastatin—atherosclerosis	0.000308	0.00232	CcSEcCtD
Daunorubicin—Pain—Simvastatin—atherosclerosis	0.000308	0.00232	CcSEcCtD
Daunorubicin—Urticaria—Lovastatin—atherosclerosis	0.000305	0.0023	CcSEcCtD
Daunorubicin—Abdominal pain—Lovastatin—atherosclerosis	0.000304	0.00229	CcSEcCtD
Daunorubicin—Body temperature increased—Lovastatin—atherosclerosis	0.000304	0.00229	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000301	0.00227	CcSEcCtD
Daunorubicin—Dizziness—Rosuvastatin—atherosclerosis	0.0003	0.00226	CcSEcCtD
Daunorubicin—Urticaria—Ezetimibe—atherosclerosis	0.0003	0.00226	CcSEcCtD
Daunorubicin—Insomnia—Niacin—atherosclerosis	0.000299	0.00225	CcSEcCtD
Daunorubicin—Body temperature increased—Ezetimibe—atherosclerosis	0.000298	0.00225	CcSEcCtD
Daunorubicin—Abdominal pain—Ezetimibe—atherosclerosis	0.000298	0.00225	CcSEcCtD
Daunorubicin—Feeling abnormal—Simvastatin—atherosclerosis	0.000296	0.00224	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000296	0.00223	CcSEcCtD
Daunorubicin—Dyspnoea—Niacin—atherosclerosis	0.000294	0.00222	CcSEcCtD
Daunorubicin—CYP1B1—adipose tissue—atherosclerosis	0.000294	0.0206	CbGeAlD
Daunorubicin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000294	0.00222	CcSEcCtD
Daunorubicin—Insomnia—Pravastatin—atherosclerosis	0.000294	0.00222	CcSEcCtD
Daunorubicin—Somnolence—Niacin—atherosclerosis	0.000294	0.00221	CcSEcCtD
Daunorubicin—Dyspnoea—Pravastatin—atherosclerosis	0.00029	0.00219	CcSEcCtD
Daunorubicin—Decreased appetite—Niacin—atherosclerosis	0.000287	0.00217	CcSEcCtD
Daunorubicin—Rash—Rosuvastatin—atherosclerosis	0.000286	0.00216	CcSEcCtD
Daunorubicin—Dermatitis—Rosuvastatin—atherosclerosis	0.000286	0.00216	CcSEcCtD
Daunorubicin—Urticaria—Simvastatin—atherosclerosis	0.000286	0.00216	CcSEcCtD
Daunorubicin—Abdominal pain—Simvastatin—atherosclerosis	0.000284	0.00214	CcSEcCtD
Daunorubicin—Body temperature increased—Simvastatin—atherosclerosis	0.000284	0.00214	CcSEcCtD
Daunorubicin—Headache—Rosuvastatin—atherosclerosis	0.000284	0.00214	CcSEcCtD
Daunorubicin—Hypersensitivity—Lovastatin—atherosclerosis	0.000283	0.00214	CcSEcCtD
Daunorubicin—Decreased appetite—Pravastatin—atherosclerosis	0.000283	0.00213	CcSEcCtD
Daunorubicin—Pain—Niacin—atherosclerosis	0.000282	0.00213	CcSEcCtD
Daunorubicin—Fatigue—Pravastatin—atherosclerosis	0.00028	0.00211	CcSEcCtD
Daunorubicin—Constipation—Pravastatin—atherosclerosis	0.000278	0.0021	CcSEcCtD
Daunorubicin—Pain—Pravastatin—atherosclerosis	0.000278	0.0021	CcSEcCtD
Daunorubicin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000278	0.0021	CcSEcCtD
Daunorubicin—Asthenia—Lovastatin—atherosclerosis	0.000276	0.00208	CcSEcCtD
Daunorubicin—ABCB1—blood vessel—atherosclerosis	0.000275	0.0192	CbGeAlD
Daunorubicin—Pruritus—Lovastatin—atherosclerosis	0.000272	0.00205	CcSEcCtD
Daunorubicin—Asthenia—Ezetimibe—atherosclerosis	0.000271	0.00204	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Niacin—atherosclerosis	0.00027	0.00204	CcSEcCtD
Daunorubicin—Nausea—Rosuvastatin—atherosclerosis	0.000269	0.00203	CcSEcCtD
Daunorubicin—Feeling abnormal—Pravastatin—atherosclerosis	0.000268	0.00202	CcSEcCtD
Daunorubicin—Pruritus—Ezetimibe—atherosclerosis	0.000267	0.00201	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000266	0.00201	CcSEcCtD
Daunorubicin—Hypersensitivity—Simvastatin—atherosclerosis	0.000265	0.002	CcSEcCtD
Daunorubicin—ABCC1—adipose tissue—atherosclerosis	0.000265	0.0185	CbGeAlD
Daunorubicin—Diarrhoea—Lovastatin—atherosclerosis	0.000263	0.00198	CcSEcCtD
Daunorubicin—ABCC10—liver—atherosclerosis	0.000262	0.0184	CbGeAlD
Daunorubicin—Urticaria—Niacin—atherosclerosis	0.000262	0.00198	CcSEcCtD
Daunorubicin—Abdominal pain—Niacin—atherosclerosis	0.000261	0.00197	CcSEcCtD
Daunorubicin—Body temperature increased—Niacin—atherosclerosis	0.000261	0.00197	CcSEcCtD
Daunorubicin—Urticaria—Pravastatin—atherosclerosis	0.000258	0.00195	CcSEcCtD
Daunorubicin—Asthenia—Simvastatin—atherosclerosis	0.000258	0.00195	CcSEcCtD
Daunorubicin—Diarrhoea—Ezetimibe—atherosclerosis	0.000258	0.00195	CcSEcCtD
Daunorubicin—Abdominal pain—Pravastatin—atherosclerosis	0.000257	0.00194	CcSEcCtD
Daunorubicin—Body temperature increased—Pravastatin—atherosclerosis	0.000257	0.00194	CcSEcCtD
Daunorubicin—Pruritus—Simvastatin—atherosclerosis	0.000254	0.00192	CcSEcCtD
Daunorubicin—Dizziness—Lovastatin—atherosclerosis	0.000254	0.00192	CcSEcCtD
Daunorubicin—Dizziness—Ezetimibe—atherosclerosis	0.000249	0.00188	CcSEcCtD
Daunorubicin—Diarrhoea—Simvastatin—atherosclerosis	0.000246	0.00186	CcSEcCtD
Daunorubicin—Vomiting—Lovastatin—atherosclerosis	0.000244	0.00184	CcSEcCtD
Daunorubicin—Hypersensitivity—Niacin—atherosclerosis	0.000243	0.00184	CcSEcCtD
Daunorubicin—Rash—Lovastatin—atherosclerosis	0.000242	0.00183	CcSEcCtD
Daunorubicin—Dermatitis—Lovastatin—atherosclerosis	0.000242	0.00183	CcSEcCtD
Daunorubicin—Headache—Lovastatin—atherosclerosis	0.000241	0.00182	CcSEcCtD
Daunorubicin—Vomiting—Ezetimibe—atherosclerosis	0.00024	0.00181	CcSEcCtD
Daunorubicin—Hypersensitivity—Pravastatin—atherosclerosis	0.00024	0.00181	CcSEcCtD
Daunorubicin—Dizziness—Simvastatin—atherosclerosis	0.000238	0.00179	CcSEcCtD
Daunorubicin—Rash—Ezetimibe—atherosclerosis	0.000238	0.00179	CcSEcCtD
Daunorubicin—Dermatitis—Ezetimibe—atherosclerosis	0.000238	0.00179	CcSEcCtD
Daunorubicin—Asthenia—Niacin—atherosclerosis	0.000237	0.00179	CcSEcCtD
Daunorubicin—Headache—Ezetimibe—atherosclerosis	0.000236	0.00178	CcSEcCtD
Daunorubicin—Pruritus—Niacin—atherosclerosis	0.000234	0.00176	CcSEcCtD
Daunorubicin—Asthenia—Pravastatin—atherosclerosis	0.000233	0.00176	CcSEcCtD
Daunorubicin—Pruritus—Pravastatin—atherosclerosis	0.00023	0.00174	CcSEcCtD
Daunorubicin—Vomiting—Simvastatin—atherosclerosis	0.000229	0.00172	CcSEcCtD
Daunorubicin—Nausea—Lovastatin—atherosclerosis	0.000228	0.00172	CcSEcCtD
Daunorubicin—Rash—Simvastatin—atherosclerosis	0.000227	0.00171	CcSEcCtD
Daunorubicin—Dermatitis—Simvastatin—atherosclerosis	0.000227	0.00171	CcSEcCtD
Daunorubicin—Diarrhoea—Niacin—atherosclerosis	0.000226	0.0017	CcSEcCtD
Daunorubicin—Headache—Simvastatin—atherosclerosis	0.000225	0.0017	CcSEcCtD
Daunorubicin—Nausea—Ezetimibe—atherosclerosis	0.000224	0.00169	CcSEcCtD
Daunorubicin—Diarrhoea—Pravastatin—atherosclerosis	0.000222	0.00168	CcSEcCtD
Daunorubicin—ABCG2—adipose tissue—atherosclerosis	0.000219	0.0153	CbGeAlD
Daunorubicin—Dizziness—Niacin—atherosclerosis	0.000218	0.00165	CcSEcCtD
Daunorubicin—Dizziness—Pravastatin—atherosclerosis	0.000215	0.00162	CcSEcCtD
Daunorubicin—Nausea—Simvastatin—atherosclerosis	0.000214	0.00161	CcSEcCtD
Daunorubicin—ABCC2—liver—atherosclerosis	0.000211	0.0148	CbGeAlD
Daunorubicin—Vomiting—Niacin—atherosclerosis	0.00021	0.00158	CcSEcCtD
Daunorubicin—Rash—Niacin—atherosclerosis	0.000208	0.00157	CcSEcCtD
Daunorubicin—Dermatitis—Niacin—atherosclerosis	0.000208	0.00157	CcSEcCtD
Daunorubicin—CYP1A1—adipose tissue—atherosclerosis	0.000208	0.0146	CbGeAlD
Daunorubicin—Headache—Niacin—atherosclerosis	0.000207	0.00156	CcSEcCtD
Daunorubicin—Vomiting—Pravastatin—atherosclerosis	0.000207	0.00156	CcSEcCtD
Daunorubicin—CYP1B1—liver—atherosclerosis	0.000206	0.0145	CbGeAlD
Daunorubicin—Rash—Pravastatin—atherosclerosis	0.000205	0.00155	CcSEcCtD
Daunorubicin—Dermatitis—Pravastatin—atherosclerosis	0.000205	0.00154	CcSEcCtD
Daunorubicin—Headache—Pravastatin—atherosclerosis	0.000204	0.00154	CcSEcCtD
Daunorubicin—CYP3A5—adipose tissue—atherosclerosis	0.000203	0.0142	CbGeAlD
Daunorubicin—Nausea—Niacin—atherosclerosis	0.000196	0.00148	CcSEcCtD
Daunorubicin—Nausea—Pravastatin—atherosclerosis	0.000193	0.00146	CcSEcCtD
Daunorubicin—ABCC1—liver—atherosclerosis	0.000186	0.013	CbGeAlD
Daunorubicin—ABCG2—liver—atherosclerosis	0.000154	0.0108	CbGeAlD
Daunorubicin—CYP1A2—liver—atherosclerosis	0.000148	0.0104	CbGeAlD
Daunorubicin—CYP1A1—liver—atherosclerosis	0.000146	0.0102	CbGeAlD
Daunorubicin—CYP3A5—liver—atherosclerosis	0.000143	0.00999	CbGeAlD
Daunorubicin—ABCB1—cardiovascular system—atherosclerosis	0.000122	0.00858	CbGeAlD
Daunorubicin—ABCB1—adipose tissue—atherosclerosis	0.000108	0.00757	CbGeAlD
Daunorubicin—CYP3A4—liver—atherosclerosis	0.000107	0.0075	CbGeAlD
Daunorubicin—ABCB1—liver—atherosclerosis	7.57e-05	0.00531	CbGeAlD
Daunorubicin—ABCC1—Disease—NOS2—atherosclerosis	8.56e-06	6.45e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOB—atherosclerosis	8.46e-06	6.38e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CD36—atherosclerosis	8.43e-06	6.36e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOB—atherosclerosis	8.37e-06	6.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	8.31e-06	6.27e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SCARB1—atherosclerosis	8.28e-06	6.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMGCR—atherosclerosis	8.27e-06	6.24e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MTHFR—atherosclerosis	8.26e-06	6.23e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.23e-06	6.21e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTM1—atherosclerosis	8.23e-06	6.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.2e-06	6.18e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTM1—atherosclerosis	8.14e-06	6.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARA—atherosclerosis	8.11e-06	6.11e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—LPL—atherosclerosis	8.07e-06	6.09e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.06e-06	6.08e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALOX5—atherosclerosis	8.03e-06	6.05e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALB—atherosclerosis	8.02e-06	6.05e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—LPL—atherosclerosis	7.99e-06	6.03e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MTHFR—atherosclerosis	7.99e-06	6.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP27A1—atherosclerosis	7.95e-06	5.99e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GPX1—atherosclerosis	7.88e-06	5.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AGT—atherosclerosis	7.85e-06	5.92e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—INS—atherosclerosis	7.85e-06	5.92e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARA—atherosclerosis	7.84e-06	5.91e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.83e-06	5.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMGCR—atherosclerosis	7.81e-06	5.89e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GPX1—atherosclerosis	7.8e-06	5.88e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.72e-06	5.82e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—APOE—atherosclerosis	7.69e-06	5.8e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CD36—atherosclerosis	7.67e-06	5.78e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—NOS3—atherosclerosis	7.67e-06	5.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.63e-06	5.76e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CAV1—atherosclerosis	7.62e-06	5.75e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—APOA1—atherosclerosis	7.6e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CD36—atherosclerosis	7.59e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AGT—atherosclerosis	7.59e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOA2—atherosclerosis	7.54e-06	5.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	7.54e-06	5.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALOX15—atherosclerosis	7.54e-06	5.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	7.54e-06	5.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCG5—atherosclerosis	7.44e-06	5.61e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—APOE—atherosclerosis	7.44e-06	5.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.44e-06	5.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCA1—atherosclerosis	7.37e-06	5.56e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CAV1—atherosclerosis	7.37e-06	5.56e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—APOA1—atherosclerosis	7.35e-06	5.55e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCG1—atherosclerosis	7.32e-06	5.52e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MTHFR—atherosclerosis	7.27e-06	5.48e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SERPINE1—atherosclerosis	7.21e-06	5.43e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NAMPT—atherosclerosis	7.2e-06	5.43e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MTHFR—atherosclerosis	7.2e-06	5.43e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LPA—atherosclerosis	7.19e-06	5.42e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LIPC—atherosclerosis	7.15e-06	5.39e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARA—atherosclerosis	7.13e-06	5.38e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOC3—atherosclerosis	7.11e-06	5.36e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LDLR—atherosclerosis	7.07e-06	5.33e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARA—atherosclerosis	7.06e-06	5.32e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.05e-06	5.32e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—atherosclerosis	7.02e-06	5.29e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCA1—atherosclerosis	6.97e-06	5.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BGN—atherosclerosis	6.96e-06	5.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CG—atherosclerosis	6.94e-06	5.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.91e-06	5.21e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AGT—atherosclerosis	6.91e-06	5.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CETP—atherosclerosis	6.9e-06	5.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOA5—atherosclerosis	6.89e-06	5.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LCAT—atherosclerosis	6.88e-06	5.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—FABP4—atherosclerosis	6.88e-06	5.19e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS3—atherosclerosis	6.88e-06	5.19e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AGT—atherosclerosis	6.84e-06	5.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.78e-06	5.11e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOE—atherosclerosis	6.77e-06	5.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOA4—atherosclerosis	6.76e-06	5.09e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CG—atherosclerosis	6.71e-06	5.06e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CAV1—atherosclerosis	6.71e-06	5.06e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—atherosclerosis	6.7e-06	5.05e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOE—atherosclerosis	6.7e-06	5.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.69e-06	5.05e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOA1—atherosclerosis	6.69e-06	5.05e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.64e-06	5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CAV1—atherosclerosis	6.64e-06	5e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	6.63e-06	5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOA1—atherosclerosis	6.62e-06	4.99e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SCARB1—atherosclerosis	6.61e-06	4.98e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—INS—atherosclerosis	6.57e-06	4.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.56e-06	4.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.5e-06	4.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.48e-06	4.89e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—atherosclerosis	6.48e-06	4.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALOX5—atherosclerosis	6.41e-06	4.83e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—INS—atherosclerosis	6.36e-06	4.79e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMOX1—atherosclerosis	6.33e-06	4.77e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—atherosclerosis	6.29e-06	4.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMGCR—atherosclerosis	6.24e-06	4.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.13e-06	4.63e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.12e-06	4.61e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—atherosclerosis	6.11e-06	4.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOB—atherosclerosis	6.06e-06	4.57e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—atherosclerosis	6.05e-06	4.56e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—atherosclerosis	6.02e-06	4.54e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—atherosclerosis	5.98e-06	4.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.92e-06	4.46e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—atherosclerosis	5.9e-06	4.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—atherosclerosis	5.89e-06	4.44e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—atherosclerosis	5.83e-06	4.4e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—atherosclerosis	5.83e-06	4.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.82e-06	4.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOA2—atherosclerosis	5.82e-06	4.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.82e-06	4.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.82e-06	4.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—LPL—atherosclerosis	5.79e-06	4.36e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—INS—atherosclerosis	5.78e-06	4.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NOS3—atherosclerosis	5.76e-06	4.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NAMPT—atherosclerosis	5.75e-06	4.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.74e-06	4.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOB—atherosclerosis	5.72e-06	4.32e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—INS—atherosclerosis	5.72e-06	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.71e-06	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LIPC—atherosclerosis	5.71e-06	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOC3—atherosclerosis	5.68e-06	4.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPX1—atherosclerosis	5.64e-06	4.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LDLR—atherosclerosis	5.64e-06	4.25e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NOS3—atherosclerosis	5.57e-06	4.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—atherosclerosis	5.57e-06	4.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ABCA1—atherosclerosis	5.56e-06	4.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LPA—atherosclerosis	5.55e-06	4.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CETP—atherosclerosis	5.51e-06	4.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CD36—atherosclerosis	5.5e-06	4.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—LPL—atherosclerosis	5.47e-06	4.12e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BGN—atherosclerosis	5.37e-06	4.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPX1—atherosclerosis	5.33e-06	4.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOA5—atherosclerosis	5.32e-06	4.01e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—atherosclerosis	5.3e-06	4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SCARB1—atherosclerosis	5.28e-06	3.98e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—atherosclerosis	5.27e-06	3.97e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—atherosclerosis	5.25e-06	3.96e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—atherosclerosis	5.21e-06	3.93e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CD36—atherosclerosis	5.19e-06	3.92e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.14e-06	3.87e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.12e-06	3.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARA—atherosclerosis	5.11e-06	3.85e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—atherosclerosis	5.1e-06	3.84e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NOS3—atherosclerosis	5.07e-06	3.82e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NOS3—atherosclerosis	5.02e-06	3.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.98e-06	3.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AGT—atherosclerosis	4.95e-06	3.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.95e-06	3.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—atherosclerosis	4.92e-06	3.71e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—atherosclerosis	4.91e-06	3.7e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOE—atherosclerosis	4.85e-06	3.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARA—atherosclerosis	4.83e-06	3.64e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAV1—atherosclerosis	4.8e-06	3.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOA1—atherosclerosis	4.79e-06	3.61e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—atherosclerosis	4.78e-06	3.61e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—atherosclerosis	4.77e-06	3.6e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK3—atherosclerosis	4.69e-06	3.54e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AGT—atherosclerosis	4.68e-06	3.53e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—atherosclerosis	4.64e-06	3.5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—atherosclerosis	4.59e-06	3.46e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOE—atherosclerosis	4.58e-06	3.45e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOB—atherosclerosis	4.57e-06	3.45e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—atherosclerosis	4.55e-06	3.43e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAV1—atherosclerosis	4.54e-06	3.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOA1—atherosclerosis	4.53e-06	3.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.49e-06	3.39e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—atherosclerosis	4.45e-06	3.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCA1—atherosclerosis	4.44e-06	3.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.44e-06	3.34e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LIPC—atherosclerosis	4.41e-06	3.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOC3—atherosclerosis	4.38e-06	3.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—atherosclerosis	4.38e-06	3.3e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LPL—atherosclerosis	4.37e-06	3.29e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LDLR—atherosclerosis	4.35e-06	3.28e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPX1—atherosclerosis	4.26e-06	3.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CETP—atherosclerosis	4.25e-06	3.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—atherosclerosis	4.22e-06	3.19e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CD36—atherosclerosis	4.15e-06	3.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—INS—atherosclerosis	4.14e-06	3.12e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—atherosclerosis	4.13e-06	3.12e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.07e-06	3.07e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—atherosclerosis	3.99e-06	3.01e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—atherosclerosis	3.93e-06	2.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—INS—atherosclerosis	3.91e-06	2.95e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARA—atherosclerosis	3.86e-06	2.91e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.85e-06	2.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.81e-06	2.87e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—atherosclerosis	3.8e-06	2.86e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AGT—atherosclerosis	3.73e-06	2.82e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOE—atherosclerosis	3.66e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOB—atherosclerosis	3.65e-06	2.75e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NOS3—atherosclerosis	3.63e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAV1—atherosclerosis	3.63e-06	2.73e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOA1—atherosclerosis	3.62e-06	2.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—atherosclerosis	3.59e-06	2.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.55e-06	2.68e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—atherosclerosis	3.53e-06	2.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LPL—atherosclerosis	3.49e-06	2.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NOS3—atherosclerosis	3.43e-06	2.59e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—atherosclerosis	3.43e-06	2.59e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.43e-06	2.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPX1—atherosclerosis	3.4e-06	2.56e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.32e-06	2.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CD36—atherosclerosis	3.31e-06	2.5e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.3e-06	2.49e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—atherosclerosis	3.19e-06	2.4e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—atherosclerosis	3.16e-06	2.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—atherosclerosis	3.14e-06	2.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.14e-06	2.37e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—INS—atherosclerosis	3.13e-06	2.36e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARA—atherosclerosis	3.08e-06	2.32e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AGT—atherosclerosis	2.98e-06	2.25e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.94e-06	2.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOE—atherosclerosis	2.92e-06	2.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAV1—atherosclerosis	2.89e-06	2.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOA1—atherosclerosis	2.89e-06	2.18e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—atherosclerosis	2.87e-06	2.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOB—atherosclerosis	2.82e-06	2.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NOS3—atherosclerosis	2.74e-06	2.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.74e-06	2.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LPL—atherosclerosis	2.69e-06	2.03e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—atherosclerosis	2.65e-06	2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.64e-06	1.99e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX1—atherosclerosis	2.62e-06	1.98e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—atherosclerosis	2.56e-06	1.93e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CD36—atherosclerosis	2.56e-06	1.93e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—atherosclerosis	2.54e-06	1.92e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—atherosclerosis	2.51e-06	1.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—INS—atherosclerosis	2.5e-06	1.88e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.42e-06	1.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARA—atherosclerosis	2.38e-06	1.79e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—atherosclerosis	2.33e-06	1.76e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—atherosclerosis	2.31e-06	1.74e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AGT—atherosclerosis	2.3e-06	1.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—atherosclerosis	2.29e-06	1.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOE—atherosclerosis	2.25e-06	1.7e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAV1—atherosclerosis	2.23e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOA1—atherosclerosis	2.23e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NOS3—atherosclerosis	2.19e-06	1.65e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.03e-06	1.53e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—atherosclerosis	2e-06	1.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—atherosclerosis	1.96e-06	1.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—INS—atherosclerosis	1.93e-06	1.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—atherosclerosis	1.77e-06	1.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NOS3—atherosclerosis	1.69e-06	1.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—atherosclerosis	1.67e-06	1.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—atherosclerosis	1.58e-06	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.54e-06	1.16e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—atherosclerosis	1.26e-06	9.5e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—atherosclerosis	1.01e-06	7.59e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—atherosclerosis	7.76e-07	5.85e-06	CbGpPWpGaD
